OBD was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases.
| CEO: |
Richard Compton |
| CFO & Executive Director: |
Paul Stockdale |
| Chief Scientific Officer: |
Alexandre Akoulitchev |
| Independent Non-Executive Director: |
David Holbrook |
| Non-Executive Chairman: |
Iain Ross |
| Non-Executive Director: |
Peter Presland, Martin Diggle |
| Address: |
3140 Rowan Place, John Smith Drive, Oxford Business Park South, Oxford, United Kingdom |
| Phone: |
+44 (0)1865 518 910 |
| Fax: |
|
| Website: |
http://www.oxfordbiodynamics.com/ |
| Email: |
|